IRIS
ORANGER, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.694
EU - Europa 1.161
AS - Asia 603
OC - Oceania 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.688
CN - Cina 395
IT - Italia 337
SE - Svezia 330
SG - Singapore 165
UA - Ucraina 148
DE - Germania 138
FI - Finlandia 90
GB - Regno Unito 53
IN - India 26
IE - Irlanda 21
FR - Francia 19
BE - Belgio 8
CZ - Repubblica Ceca 7
IR - Iran 7
CA - Canada 6
AT - Austria 3
AU - Australia 3
KR - Corea 3
VN - Vietnam 3
LT - Lituania 2
NL - Olanda 2
RO - Romania 2
AR - Argentina 1
AZ - Azerbaigian 1
BO - Bolivia 1
EU - Europa 1
HR - Croazia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
TR - Turchia 1
Totale 5.464
Salva come PNG Salva come JPEG
Città #
Fairfield 400
Chandler 390
Jacksonville 355
Woodbridge 331
Nyköping 243
Houston 227
Bari 201
Ashburn 190
Cambridge 178
Ann Arbor 170
Seattle 155
Wilmington 133
Singapore 123
Roxbury 92
Lawrence 90
Nanjing 86
Beijing 63
Des Moines 62
New York 62
Boardman 54
Princeton 42
Inglewood 38
Dearborn 37
Brooklyn 32
San Diego 31
Shenyang 31
Nanchang 25
Los Angeles 23
Pune 23
Santa Clara 22
Dublin 21
London 20
Changsha 17
Hebei 17
Jiaxing 17
Munich 16
Noicattaro 15
Tianjin 14
Trani 14
Redwood City 12
Guangzhou 11
Paris 10
Boydton 9
Hefei 9
Orta Nova 9
Wuhan 9
Brussels 8
Ardabil 7
Brno 7
Falls Church 7
Helsinki 7
Kunming 7
Melito Di Napoli 7
Norwalk 7
Rome 7
Leawood 6
San Mateo 6
Bologna 5
Grumo Appula 5
Indiana 5
Jinan 5
Shanghai 5
Toronto 5
Washington 4
Augusta 3
Dong Ket 3
Frankfurt am Main 3
Fuzhou 3
Kilburn 3
Milan 3
Nanning 3
Ningbo 3
Nürnberg 3
Quanzhou 3
Taizhou 3
Wuxi 3
Acton 2
Auburn Hills 2
Chengdu 2
Chiswick 2
Grottaglie 2
Heze 2
Mottola 2
Mumbai 2
Novi Ligure 2
Pieve di Cento 2
Qingdao 2
Roccapiemonte 2
San Francisco 2
Strasbourg 2
Turin 2
Vienna 2
Xian 2
Zhengzhou 2
Agoura Hills 1
Almaty 1
Ankara 1
Baku 1
Bitritto 1
Brisbane 1
Totale 4.317
Salva come PNG Salva come JPEG
Nome #
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 143
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α 132
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems 130
Sclerostin stimulates angiogenesis in human endothelial cells 113
TRAIL effect on osteoclast formation in physiological and pathological conditions 108
Osteogenic differentiation of dental follicle stem cells. 102
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 100
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 95
Sclerostin is overexpressed by plasma cells from multiple myeloma patients 92
In vitro osteoclastogenesis and T-cell RANKL expression in multiple myeloma-bone disease at diagnosis and in the setting of frontline treatment 90
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 88
TRAIL is involved in human osteoclast apoptosis 87
Aortic valvular interstitial cells apoptosis and calcification is mediated by TNF-related apoptosis-inducing ligand 87
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 75
Alteration of the osteogenic properties of bone marrow stromal cells from multiple myeloma bone disease patients 74
null 74
Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 73
Elevati livelli sierici di Dkk1, antagonista del segnale di WNT in bambini obesi. 72
The Role of LIGHT in Multiple Myeloma-Bone Disease 72
null 71
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process 71
Alteration of bone remodeling in multiple myeloma bone disease: role of sclerostin 70
THE ROLE OF LIGHT ON BONE REMODELING 68
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 68
Cellular mechanisms of multiple myeloma bone disease 67
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 66
Myeloma cells suppress osteoblasts through sclerostin secretion 66
T cells support osteoclastogenesis in an in vitro model derived from psoritic arthritis 64
Another link between bone and immune system: LIGHT 64
Altered osteogenic properties of bone marrow stromal cells from multiple myeloma patients 64
null 63
Alterazione delle capacità osteogeniche in cellule stromali ottenute da midollo osseo di pazienti affetti da mieloma multiplo 63
Dental pulp stem cells: osteogenic differentiation and genes expression 62
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 62
Alterazione del rimodellamento osseo in soggetti in età pediatrica affetti da deficit di 21-idrossilasi (21-OHD): ruolo di DKK1 60
The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis 60
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 59
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 57
Alterazione del potenziale osteogenico in osteoblasti ottenuti da soggetti affetti da malattia parodontale: ruolo dei recettori apoptotici per TRAIL 57
null 57
Shedding “LIGHT” on the Link between Bone and Fat in Obese Children and Adolescents 57
Mechanism of Bone Disease in Prader-Willi Syndrome 53
Myeloma cells induce osteoblast suppression through sclerostin secretion 53
Failure of an in vitro model of osteoclastogenesis in human plasma cell leukaemia (PCL) 53
The effect of Irisin on bone cells in vivo and in vitro 53
Spontaneous osteoclastogenesis TNF-a and RANKL mediated in patients with Turner syndrome. 52
Osteoclast apoptosis: Role of TRAIL and its receptors 52
Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL 52
Soluble decoy receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients 51
Sclerostin, produced by myeloma plasma cell, suppresses osteoblast activity 51
No spontaneous osteoclast formation in an in vitro model derived from primary plasma cell leukemia 50
The role of the Wnt-signaling antagonist Sclerostin in the development of osteolytic lesions in multiple myeloma 49
LIGHT: another link between bone and immune system 49
null 49
Osteogenic properties of human dental pulp stem cells 48
LIGHT: a new potential molecule involved in bone loss 47
Impairment of osteoblast diffeentiation and activity through sclerostin in multiple myeloma bone disease ??? 47
DcR3 involvement in multiple myeloma bone disease 46
DCR3 involvement in multiple myeloma bone disease 46
Osteoclast formation in Multiple Myeloma bone disease patients: role of DcR3 45
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 45
Formazione e sopravvivenza di osteoclasti in pazienti affetti da mieloma multiplo: ruolo di DcR3 44
Ridotta attività degli osteoblasti nel mieloma multiplo: ruolo della sclerostina 43
Survival and formation of osteoclasts from multiple myeloma bone disease patients: role of decoy receptor 3 (DCR3) 43
LIGHT INVOLVEMENT IN MULTIPLE MYELOMA-OSTEOLYTIC BONE DISEASE 43
The role of the Wnt-signaling antagonist sclerostin in the development of osteolytic lesions in multiple myeloma 42
Circulating levels of cathepsin-k in multiple myeloma patients 42
High serum levels of the WNT-signaling antagonist Dkk1 in children with 21-hydroxylase deficiency (21-OHD) 41
Evaluation of serum levels of cathepsin k in multiple myeloma patients 41
null 41
Inhibition of osteoclast apoptosis in multiple myeloma bone diseases: role of DCR3 40
High serum levels of the WNT-signaling antagonist Dkk1 in obese children 39
Irisin and Secondary Osteoporosis in Humans 39
DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNFα up-regulation 37
Le cellule T supportano la formazione di osteoclasti in vitro in campioni di sangue periferico ottenuti da pazienti affetti da artrite psoriasica 37
Osteoclastogensi spontanea TNF-alpha e RANKL mediata in pazienti con Sindrome di Turner 37
TRAIL effect on osteoclast formation in multiple myeloma-bone disease 36
Shedding LIGHT on bone cell differentiation and Multiple Myeloma-bone disease 36
Osteoblast apoptosis in periodontal disease: role of TRAIL 36
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 35
IN VITRO EVALUATION OF OSTEOGENIC PROPERTIES OF HUMAN DENTAL PULP STEM CELLS 35
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 34
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 34
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 33
Decoy Receptor 3 DcR3 supports osteoclast formation in multiple myeloma bone disease patients through RANKL and TNF-ALPHA up-regulation 32
Ruolo di LIGHT (tnfsf14) nella malattia ossea associata al mieloma multiplo 31
ROLE OF DCR3 ON OSTEOCLAST FORMATION IN MULTIPLE MYELOMA BONE DISEASE PATIENTS 31
Bone Cells 29
Detection of the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 28
Suppressed osteoblast differentiation and activity in multiple myeloma bone disease: role of sclerostin 27
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 27
Ridotta attività degli osteoclasti nel mieloma multiplo: ruolo di sclerostina 26
Osteoclast formation and survival in multiple myeloma bone disease patients: role of DcR3 26
The role of light (TNFSF14) on bone remodeling 25
The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of solubile decoy receptor 3 24
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 22
Role of DcR3 on osteoclast formation in multiple myeloma bone disease patients. 21
Solubile decoy receptor 3 (DCR3) modulates the survival of osteoclasts derived from patients with multiple myeloma lytic bone disease 20
DcR3 involvement in multiple myeloma bone disease 19
High levels of LIGHT/TNFSF14 in patients with Prader–Willi syndrome 18
Totale 5.488
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020706 0 0 0 0 92 73 133 77 120 60 129 22
2020/2021814 92 27 78 22 89 48 86 52 110 112 65 33
2021/2022777 23 103 5 32 25 48 27 33 125 40 130 186
2022/20231.129 163 122 63 83 140 134 21 129 221 4 19 30
2023/2024424 43 83 13 27 37 112 8 4 1 29 25 42
2024/2025390 127 27 140 69 27 0 0 0 0 0 0 0
Totale 5.623